Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1987-11-6
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0300-9157
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
10-5
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:2889275-Administration, Oral,
pubmed-meshheading:2889275-Adult,
pubmed-meshheading:2889275-Arthritis, Rheumatoid,
pubmed-meshheading:2889275-Female,
pubmed-meshheading:2889275-Humans,
pubmed-meshheading:2889275-Male,
pubmed-meshheading:2889275-Middle Aged,
pubmed-meshheading:2889275-Sulfasalazine
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Sulfasalazine therapy in patients with rheumatoid arthritis].
|
pubmed:publicationType |
Journal Article,
English Abstract
|